MicroPort CardioFlow Medtech Corporation
Overview
MicroPort CardioFlow Medtech Corporation is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| 4C Medical Technologies, Inc. | Mar 2025 | Series D | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is MicroPort CardioFlow Medtech Corporation based?
MicroPort CardioFlow Medtech Corporation is headquartered in Shanghai, Shanghai, China.
When was MicroPort CardioFlow Medtech Corporation founded?
MicroPort CardioFlow Medtech Corporation was founded in 2009.
How many portfolio companies does MicroPort CardioFlow Medtech Corporation have?
MicroPort CardioFlow Medtech Corporation has 1 portfolio company in Caplight's dataset.
What are some companies in MicroPort CardioFlow Medtech Corporation's portfolio?
Portfolio companies visible on Caplight include 4C Medical Technologies, Inc..
What was MicroPort CardioFlow Medtech Corporation's most recent investment shown here?
MicroPort CardioFlow Medtech Corporation's most recent investment in this portfolio sample was in 4C Medical Technologies, Inc. in 2025.
What sectors does MicroPort CardioFlow Medtech Corporation focus on?
MicroPort CardioFlow Medtech Corporation focuses on Healthcare & Life Sciences.
What company stages does MicroPort CardioFlow Medtech Corporation focus on?
Stage focus information for MicroPort CardioFlow Medtech Corporation is not publicly available.
What is MicroPort CardioFlow Medtech Corporation's AUM?
MicroPort CardioFlow Medtech Corporation's assets under management are estimated between $100.0M and $250.0M.